The Ganglioside Ab IgG Panel test is primarily used to diagnose and monitor autoimmune neurological disorders such as Guillain-Barré Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). This test helps detect IgG antibodies against gangliosides, differentiate between neurological disease types, assess disease progression, and monitor treatment effectiveness.